These are tumors that develop in muscle tissue, like the muscles in your arms, legs, or heart. This doesn't include tumors that are just in the muscles themselves.
Every report comes from a Lived member, sent anonymously.
Have you had Surgery for Muscle Tissue Tumors?
Muscle tissue tumors are growths made of cells that look and behave like muscle cells. The body has three kinds of muscle: skeletal muscle, which moves the limbs and trunk; heart muscle; and smooth muscle, which lines hollow organs such as the uterus, stomach, intestines, bladder and blood vessels. The label describes what a tumor is made of, not where it sits, so a fatty or nerve tumor that happens to lie inside a muscle does not belong to this group. This is an umbrella term, not a single disease, and the members range from very common and harmless to rare and serious. Noncancerous (benign) muscle tumors include leiomyomas, smooth muscle growths best known as uterine fibroids, which are the most common benign tumors in women of childbearing age, and rhabdomyomas, which most often appear in the heart of a fetus or infant. The cancers are sarcomas: leiomyosarcoma, an aggressive smooth muscle cancer usually found in adults in the abdomen or uterus, and rhabdomyosarcoma, the most common soft tissue cancer in children. The older name myoblastoma refers to the granular cell tumor, which is now known to come from nerve-sheath cells and is usually benign. Knowing exactly which type is present matters more than the umbrella label, because it decides the treatment and the outlook.
For most muscle tissue tumors, no single cause is known, and nothing a person did typically explains why one formed. Fibroids depend partly on the hormones estrogen and progesterone, which is why they appear during the reproductive years and often shrink after menopause. They are more likely with older age within those years, a family history, and among Black women, who also tend to develop them younger and with more symptoms. The sarcomas are linked to certain inherited conditions that raise cancer risk in general, including Li-Fraumeni syndrome and neurofibromatosis type 1; several rarer syndromes, such as Costello, Beckwith-Wiedemann and Noonan syndrome, are tied to rhabdomyosarcoma in children. Earlier radiation treatment and some chemical exposures increase the risk of soft tissue sarcomas. Still, most people with leiomyosarcoma or rhabdomyosarcoma have none of these risk factors. Heart rhabdomyomas found before or soon after birth are strongly associated with tuberous sclerosis, a genetic condition that also affects the brain, skin and kidneys; in one large review, about 60% of affected babies were diagnosed with it.
How a muscle tumor comes to attention depends on where it is. A fibroid may be felt during a pelvic exam or seen on ultrasound, often while looking into heavy periods. A sarcoma may show up as a lump that keeps growing, or as pain, swelling or pressure on nearby organs. A heart rhabdomyoma is often first seen on a routine prenatal ultrasound. Imaging such as ultrasound, MRI, CT or PET shows the tumor's size and position and whether anything has spread. Imaging cannot reliably tell a benign tumor from a cancer, though, and a sarcoma can look like something else on a scan. The type is confirmed by a biopsy: a tissue sample, usually taken with a needle, that a pathologist (a doctor who diagnoses disease from tissue) examines under the microscope, often with special stains. Because these tumors are uncommon and easy to misclassify, review by a pathologist experienced with sarcomas is valuable when cancer is possible. Once a sarcoma is confirmed, further scans stage it, meaning they map how far it has spread, which shapes treatment.
Treatment depends almost entirely on the type of tumor. Benign tumors that cause no problems are often simply watched. Fibroids without symptoms may need no treatment at all; when they cause heavy bleeding, pain or pressure, options range from medicines that reduce bleeding or slow growth to procedures that remove the fibroids (myomectomy) or the uterus (hysterectomy), chosen partly on whether someone wants a future pregnancy. One decision-changing detail: a uterine sarcoma can be hard to tell from a fibroid before surgery, and the US Food and Drug Administration warns that cutting tissue into pieces inside the abdomen with a power morcellator can spread a hidden cancer, so it is worth asking how tissue will be removed. Heart rhabdomyomas in infants often shrink on their own and are usually monitored; surgery is reserved for those that block blood flow or cause serious rhythm problems, and drugs called mTOR inhibitors, which act on the pathway disrupted in tuberous sclerosis, have shrunk some of these tumors in small case series. Granular cell tumors are usually removed surgically. The sarcomas need care from a team experienced in treating them. For leiomyosarcoma, surgery that removes the whole tumor with a margin of healthy tissue is the main treatment and gives the best chance of cure; radiation may be added around the time of surgery to lower the chance of regrowth, and chemotherapy is used when the tumor is large or has spread. Rhabdomyosarcoma in children is treated with a combination of chemotherapy, surgery and radiation, planned by a pediatric cancer team, with the order depending on the tumor's location, size, type and spread. Because these cancers are rare, clinical trials are a reasonable option to discuss at any stage.
The outlook spans the full range. Many fibroids never cause trouble, and those that do can usually be controlled; they tend to shrink after menopause. Heart rhabdomyomas often become smaller over the first years of life, although a child with tuberous sclerosis will need ongoing care for that condition's other effects, such as seizures. For the sarcomas, the course depends mainly on the tumor's location, whether it has spread, and whether surgery can remove all of it. Leiomyosarcoma found early and completely removed has a good chance of cure, while tumors that are large or have spread are harder to treat. After treatment, regular follow-up scans and visits look for the cancer coming back, since recurrence can occur in the same place or elsewhere. Children treated for rhabdomyosarcoma also need long-term follow-up for late effects of treatment, which can include problems with growth, teeth, eyes or digestion, fertility, learning and memory, and a higher risk of a second cancer. Many of these can be managed when they are caught early, which is why survivorship care continues long after treatment ends.
Arrange a medical visit for a lump or swelling, in any part of the body, that keeps getting bigger or does not go away, whether or not it hurts. Heavy or prolonged periods, pelvic pressure or pain, or frequent urination are reasons to be checked for fibroids. In a child, a growing lump, a bulging or newly crossed eye, blood in the urine, unexplained bleeding from the nose, throat, vagina or rectum, or new trouble passing urine or stool should be seen promptly. If you are being treated or monitored for a muscle tissue tumor, contact your care team about new pain, a lump at or near a treated site, unexplained weight loss, or ongoing nausea and vomiting, since these can be signs that a sarcoma has grown or returned.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Muscle Tissue Tumors is like, what's helped you, or ask the community a question.